RecruitingNCT05960747

Improvement to Perform Thoracocentesis After a Specific Training in Medical Students With the Supervised Use of an Augmented Reality Simulator


Sponsor

University Hospital, Strasbourg, France

Enrollment

340 participants

Start Date

Feb 15, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Monocentric study, aiming to assess the improvement of medical students to perform a first-time thoracentesis after training using a specific training using an augmented virtual reality simulator, versus standard training. Study population: medical students from the department of Respirology (University hospital of Strasbourg), performing their first thoracocentesis in patients having an indication for a first-time thoracocentesis. This is not an interventional study, no change in patient course being induced because of the study. After the procedure: use of specific surveys for the patient and for medical students to assess the patient's pain, the patient and the medical student level of anxiety, and the student ability during the procedure.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Simulation group for people with frist time indication to perform a thoracentesis, medical student training, and other related conditions. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSimulation group

Specific training for medical students by using an augmented virtual reality simulator for thoracentesis


Locations(2)

Hopitaux Universitaire de Strasbourg

Strasbourg, Bas-Rhin, France

Hôpitaux Universitaires de Strasbourg

Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05960747


Related Trials